These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18477662)

  • 41. Neurosteroid PREGS protects neurite growth and survival of newborn neurons in the hippocampal dentate gyrus of APPswe/PS1dE9 mice.
    Xu B; Yang R; Chang F; Chen L; Xie G; Sokabe M; Chen L
    Curr Alzheimer Res; 2012 Mar; 9(3):361-72. PubMed ID: 22272612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered levels of synapsin I, dopamine transporter, dynorphin A, and neuropeptide Y in the nucleus accumbens and striatum at post-puberty in rats treated neonatally with pregnenolone or DHEA.
    Muneoka K; Iwata M; Shirayama Y
    Int J Dev Neurosci; 2009 Oct; 27(6):575-81. PubMed ID: 19560533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum levels of cholesterol, pregnenolone, DHEA, and their sulfate conjugates based on sex and pubertal stage in adolescents.
    Kim SH; Lee SH; Lee WY; Lee J; Chung BC; Park MJ; Choi MH
    Clin Chim Acta; 2016 Oct; 461():47-52. PubMed ID: 27475977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach.
    Martiskainen H; Helisalmi S; Viswanathan J; Kurki M; Hall A; Herukka SK; Sarajärvi T; Natunen T; Kurkinen KM; Huovinen J; Mäkinen P; Laitinen M; Koivisto AM; Mattila KM; Lehtimäki T; Remes AM; Leinonen V; Haapasalo A; Soininen H; Hiltunen M
    J Alzheimers Dis; 2015; 43(2):565-73. PubMed ID: 25096612
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurosteroids and self-reported pain in veterans who served in the U.S. Military after September 11, 2001.
    Kilts JD; Tupler LA; Keefe FJ; Payne VM; Hamer RM; Naylor JC; Calnaido RP; Morey RA; Strauss JL; Parke G; Massing MW; Youssef NA; Shampine LJ; ; Marx CE
    Pain Med; 2010 Oct; 11(10):1469-76. PubMed ID: 20735755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease.
    Kimura A; Yoshikura N; Hayashi Y; Inuzuka T
    J Alzheimers Dis; 2018; 61(2):581-588. PubMed ID: 29171996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.
    Pettigrew C; Soldan A; Sloane K; Cai Q; Wang J; Wang MC; Moghekar A; Miller MI; Albert M;
    Neuroimage Clin; 2017; 16():439-446. PubMed ID: 28879085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exploratory investigation of biomarker candidates for suicide in schizophrenia and bipolar disorder.
    Youssef NA; Bradford DW; Kilts JD; Szabo ST; Naylor JC; Allen TB; Strauss JL; Hamer RM; Brancu M; Shampine LJ; Marx CE
    Crisis; 2015; 36(1):46-54. PubMed ID: 25410258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simultaneous determination of pregnenolone sulphate, dehydroepiandrosterone and allopregnanolone in rat brain areas by liquid chromatography-electrospray tandem mass spectrometry.
    Rustichelli C; Pinetti D; Lucchi C; Ravazzini F; Puia G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 930():62-9. PubMed ID: 23727868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between naturally occurring anti-amyloid β autoantibodies and medial temporal lobe atrophy in Alzheimer's disease.
    Kimura A; Takemura M; Saito K; Yoshikura N; Hayashi Y; Inuzuka T
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):126-131. PubMed ID: 27330118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease.
    de la Monte SM; Volicer L; Hauser SL; Wands JR
    Ann Neurol; 1992 Dec; 32(6):733-42. PubMed ID: 1471863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A study of a dendritic marker, microtubule-associated protein 2 (MAP-2), in rats neonatally treated neurosteroids, pregnenolone and dehydroepiandrosterone (DHEA).
    Iwata M; Muneoka KT; Shirayama Y; Yamamoto A; Kawahara R
    Neurosci Lett; 2005 Oct; 386(3):145-9. PubMed ID: 16002213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pregnenolone and dehydroepiandrosterone administration in neonatal rats alters the immunoreactivity of hippocampal synapsin I, neuropeptide Y and glial fibrillary acidic protein at post-puberty.
    Shirayama Y; Muneoka KT; Iwata M; Ishida H; Hazama G; Kawahara R
    Neuroscience; 2005; 133(1):147-57. PubMed ID: 15893638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simultaneous radioimmunoassay of progesterone, androst-4-enedione, pregnenolone, dehydroepiandrosterone and 17-hydroxyprogesterone in specific regions of human brain.
    Lacroix C; Fiet J; Benais JP; Gueux B; Bonete R; Villette JM; Gourmel B; Dreux C
    J Steroid Biochem; 1987 Sep; 28(3):317-25. PubMed ID: 2958661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ABCA1-Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease.
    Yassine HN; Feng Q; Chiang J; Petrosspour LM; Fonteh AN; Chui HC; Harrington MG
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology.
    Miners JS; Kehoe PG; Love S; Zetterberg H; Blennow K
    Alzheimers Res Ther; 2019 Sep; 11(1):81. PubMed ID: 31521199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Neurosteroid dehydroepiandrosterone and brain function].
    Goncharov NP; Katsia GV
    Fiziol Cheloveka; 2013; 39(6):120-8. PubMed ID: 25509179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's disease.
    Lim B; Fowler C; Li QX; Rowe C; Dhiman K; Gupta VB; Masters CL; Doecke JD; Martins RN; Collins S; Diamandis EP
    Neurosci Lett; 2020 Jul; 731():135078. PubMed ID: 32450185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.